ID |
IPI |
Description |
Subcellular localization |
Protein abundance and peptides identification |
GroSize |
ProGroup |
PM |
Cyto |
Mito |
rER |
sER |
Nucl |
4201 |
IPI00643583.2 |
Roadblock-1 |
Cyto(SP) |
- |
- |
- |
- |
- |
3.09E-01 (DIDPQNDLTFLR;GVQGIIVVNTEGIPIK) |
2 |
IPI00412497.2, IPI00643583.2
|
4202 |
IPI00643587.1 |
FBXL17 protein |
Nucl(G2) |
- |
3.06E-02 (EPPPETPDINQLPPSILLK;RKGAGVPACTPCK) |
- |
- |
- |
- |
1 |
IPI00643587.1
|
4203 |
IPI00643591.2 |
AP-1 complex subunit gamma-1 |
Cyto(G2,SP,GO) |
- |
7.18E-02 (AALCAVHVIR;ELLYFLDSCEPEFK;NVGNAILYETVLTIMDIK;TFQLQLLSPSSSIVPAFNTGTITQVIK;VLAINILGR;VLTTAGSYVR;KVPELMEMFLPATK) |
- |
2.54E-02 (NDDDSSEAMNDILAQVATNTETSK;NVGNAILYETVLTIMDIK;YVALTSLLK) |
9.07E-02 (AVEYNALFK;NVGNAILYETVLTIMDIK;TFQLQLLSPSSSIVPAFNTGTITQVIK;YVALTSLLK;TVQTDHNAVQRHR;IGYLGAMLLLDER) |
- |
2 |
IPI00293396.5, IPI00643591.2
|
4204 |
IPI00643623.1 |
Lipocalin 2 |
Nucl(G1) |
- |
8.60E-02 (SLGLPENHIVFPVPIDQCIDG;VPLQQNFQDNQFQGK) |
- |
5.16E-01 (ELTSELKENFIR;MYATIYELK;SYPGLTSYLVR;VPLQQNFQDNQFQGK;VVSTNYNQHAMVFFK) |
- |
7.73E-01 (ELTSELKENFIR;SLGLPENHIVFPVPIDQCIDG;SYPGLTSYLVR;VPLQQNFQDNQFQGK;WYVVGLAGNAILR;TFVPGCQPGEFTLGNIK) |
3 |
IPI00299547.4, IPI00643623.1, IPI00743064.1
|
4205 |
IPI00643649.1 |
MHC class II lymphocyte antigen beta chain precursor |
ER(G1) |
- |
- |
- |
- |
2.28E-01 (FDSDVGEFR;WFLNGQEETAGVVSTNLIR;HNYELDEAVTLQR) |
- |
5 |
IPI00744160.1, IPI00647764.1, IPI00645451.1, IPI00643649.1, IPI00641173.5
|
4206 |
IPI00643662.3 |
Isoform E of SH3 and multiple ankyrin repeat domains protein 2 |
Nucl(G2) |
- |
5.91E-03 (PGEGLDSPMGAK;QRPSSRCFPAGSDMNSVYER) |
- |
1.25E-02 (CFPAGSDMNSVYER;DNEGFGFVLR;VLLRSNSDNNLNASAPDWAVCSTATSHR) |
- |
- |
2 |
IPI00643662.3, IPI00791904.1
|
4207 |
IPI00643664.1 |
staufen isoform c |
Nucl(G2) |
- |
- |
- |
3.39E-02 (NAAENMLEILGFK;NLPVNFESFPLK;NAAIAVLEELKKLPPLPAVER) |
- |
- |
1 |
IPI00643664.1
|
4208 |
IPI00643720.3 |
Oxoglutarate dehydrogenase-like |
Mito(G1) |
- |
1.74E-02 (LAFYDLQEADLDKEFQLPTTTFIGGSENTLSLR;LVEDHLAVQSLIR;EASEEAFSGSAQPRPPSVVHESR;KPLIIFTPK;DVVVDLVCYR;GHHVAQLDPLGILDADLDSFVPSDLITTIDK) |
2.60E-01 (GHHVAQLDPLGILDADLDSFVPSDLITTIDK;LAFYDLQEADLDKEFQLPTTTFIGGSENTLSLR;LVEDHLAVQSLIR;EASEEAFSGSAQPRPPSVVHESR;LEQISPFPFDLIK;KPLIIFTPK;DVVVDLVCYR;LNVLANVIR;NITLSLVANPSHLEAVDPVVQGK;FLDTAFNLQAFEGK) |
1.51E-02 (LNVLANVIR;LEQISPFPFDLIK) |
- |
- |
1 |
IPI00643720.3
|
4209 |
IPI00643722.1 |
Isoform 1 of AT-rich interactive domain-containing protein 1A |
Nucl(SP,GO,HPA) |
- |
- |
- |
- |
1.13E-02 (PYGPNMANMPPQVGSGMCPPPGGMNR;IGGGDTTEHIQTHFESKTELLPSR) |
3.70E-02 (FPFGISPAQSHR;LSIQDNNVDLILATPPFSR;KHVTTAEGTPGTTDQEGPPPDGPPEKR) |
2 |
IPI00643722.1, IPI00642705.1
|
4210 |
IPI00643920.2 |
Transketolase |
Cyto(G1,GO) |
- |
1.54E+00 (SKDDQVTVIGAGVTLHEALAAAELLK;ILATPPQEDAPSVDIANIR;NSTFSEIFKK;SKDDQVTVIGAGVTLHEALAAAELLKK;ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR;SVPTSTVFYPSDGVATEK;TSRPENAIIYNNNEDFQVGQAK;TVPFCSTFAAFFTR;VLDPFTIKPL |
- |
- |
2.20E-02 (TSRPENAIIYNNNEDFQVGQAK;ILATPPQEDAPSVDIANIR) |
2.61E-01 (ILATPPQEDAPSVDIANIR;SKDDQVTVIGAGVTLHEALAAAELLK;SVPTSTVFYPSDGVATEK;TSRPENAIIYNNNEDFQVGQAK;TVPFCSTFAAFFTR;LDNLVAILDINR) |
2 |
IPI00643920.2, IPI00788802.1
|
4211 |
IPI00643974.1 |
Major histocompatibility complex, class II, DP beta 1 |
ER(G1) |
- |
- |
- |
- |
2.54E-01 (ATPENYLFQGR;FDSDVGEFR;HNYELGGPMTLQR;WFLNGQEETAGVVSTNLIR;AVTELGRPEAEYWNSQK) |
- |
2 |
IPI00645418.1, IPI00643974.1
|
4212 |
IPI00644079.2 |
Heterogeneous nuclear ribonucleoprotein U isoform a |
Nucl(G1,SP,GO); Cyto(SP); PM(SP) |
- |
1.43E-01 (EKPYFPIPEEYTFIQNVPLEDR;NFILDQTNVSAAAQR;PLFPHVLCHNCAVEFNFGQK;GNFTLPEVAECFDEITYVELQKEEAQK;FIEIAAR;YNILGTNTIMDK;GYFEYIEENKYSR) |
- |
8.22E-02 (EKPYFPIPEEYTFIQNVPLEDR;NFILDQTNVSAAAQR;YNILGTNTIMDK;GYFEYIEENK) |
4.01E-02 (NFILDQTNVSAAAQR;EKPYFPIPEEYTFIQNVPLEDR) |
7.14E-01 (EKPYFPIPEEYTFIQNVPLEDR;NFILDQTNVSAAAQR;PLFPHVLCHNCAVEFNFGQK;GYFEYIEENK;GYFEYIEENKYSR;SSGPTSLFAVTVAPPGAR) |
2 |
IPI00479217.1, IPI00644079.2
|
4213 |
IPI00644127.1 |
Isoleucyl-tRNA synthetase, cytoplasmic |
Cyto(SP,GO,HPA); Nucl(GO,HPA) |
- |
1.66E-01 (APLKPYPVSPSDK;SEGTYLNSVIESHTEFIFTTIK;EEEGTGVVHQAPYFGAEDYR;EIVVIHQDPEALK;FVDILTNWYVR;ILEFWTEFNCFQECLK;LFLNETQTQEITEDIPVK;NTELAVFHDETEIQNQTDLLSLSGK;NVIVNGLVLASDGQK;QLSSEELEQFQK;TGTIVVEGHELHDED |
- |
- |
- |
- |
1 |
IPI00644127.1
|
4214 |
IPI00644231.2 |
cytoplasmic FMR1 interacting protein 1 isoform a |
Cyto(G2) |
- |
- |
- |
1.95E-02 (FINMFAVLDELK;YAPLHLVPLIER;FQILNDEIITILDK) |
3.00E-02 (FQILNDEIITILDK;NQGATIHLPPSNR;SLLQGTILQYVK;KFQILNDEIITILDK;ALNLAYSSIYGSYR;SSLEGPTILDIEK) |
- |
1 |
IPI00644231.2
|
4215 |
IPI00644296.1 |
Tenascin XB |
Cyto(G2) |
- |
- |
- |
4.86E-03 (ESEVTVGGLEPGHK;PQVVPVEGPER;DLRSGTLYSLTLYGLRGPHK;VGPVSAVGLTAPGK) |
- |
- |
2 |
IPI00644296.1, IPI00643914.2
|
4216 |
IPI00644301.1 |
Utrophin |
Cyto(G2) |
- |
5.28E-03 (EEIAPINFKVK;MMAVVRTSLQK) |
- |
- |
- |
- |
1 |
IPI00644301.1
|
4217 |
IPI00644338.1 |
Protein |
Nucl(G2) |
- |
2.99E-02 (QSAGPNSPTGGGGGGGSGGTR;IHNASAVCLRAPVSESLSR) |
- |
- |
- |
- |
1 |
IPI00644338.1
|
4218 |
IPI00644342.2 |
CYP3A43 protein |
ER(G2) |
4.00E-02 (LQEEIDAVLPNK;DIEINGVFIPK) |
1.42E-02 (LQEEIDAVLPNK;DIEINGVFIPK) |
2.23E-02 (LQEEIDAVLPNK;YVGEKPEAGSR) |
3.97E-02 (LQEEIDAVLPNK;APVTYDALVQMEYLDMVVNETLR) |
2.17E-02 (LQEEIDAVLPNK;APVTYDALVQMEYLDMVVNETLR) |
- |
1 |
IPI00644342.2
|
4219 |
IPI00644361.2 |
Arylamine N-acetyltransferase 1 |
Cyto(SP,GO) |
- |
3.53E-02 (FNYKDNTDLIEFK;SYQMWQPLELISGKDQPQVPCVFR) |
- |
- |
- |
- |
2 |
IPI00644361.2, IPI00787523.1
|
4220 |
IPI00644386.1 |
Isoform 2 of Far upstream element-binding protein 1 |
Nucl(G1,GO,HPA) |
- |
1.27E-02 (FAVGIVIGR;IQFKPDDGTTPER) |
- |
- |
- |
6.10E-01 (FAVGIVIGR;AWEEYYK;IGGDAGTSLNSNDYGYGGQK;IQIAPDSGGLPER;VPDGMVGFIIGR;CQHAAEIITDLLR;IGGNEGIDVPIPR;IQFKPDDGTTPER;LLDQIVEK;MADYSTVPPPSSGSAGGGGGGGGGGGVNDAFKDALQR) |
3 |
IPI00788671.1, IPI00644386.1, IPI00375441.2
|
4221 |
IPI00644482.1 |
Hepatocellular carcinoma susceptibility protein |
Cyto(G2) |
- |
3.72E-02 (CIPEIDDSEFCIRIPGGGITKTLYDESCSK;VIVLSSSHSYQR) |
- |
- |
- |
- |
1 |
IPI00644482.1
|
4222 |
IPI00644591.3 |
hypothetical protein LOC64423 isoform 2 |
Cyto(SP,GO,HPA); ER(GO,HPA); Nucl(GO,HPA) |
- |
5.14E-02 (ATEPVATSNPAGDPVGSTR;DLEQPSQAAGINLEIIR;IGNFLNYGSHTGDADGFK;VTLLHHVLEEAEK;EPTMVAPR) |
- |
- |
- |
2.31E-02 (AGDTTKFDVEVLKQLLK;ALDELFEAIEQKQR) |
1 |
IPI00644591.3
|
4223 |
IPI00644623.3 |
MGC39497 protein |
Cyto(G2) |
7.01E-02 (AQSLPLAVGGVLKLR;AQSLPLAVGGVLK) |
- |
- |
- |
- |
- |
3 |
IPI00167040.2, IPI00426028.1, IPI00644623.3
|
4224 |
IPI00644631.3 |
HLA class I histocompatibility antigen, A-2 alpha chain precursor |
ER(G1); PM(GO) |
- |
- |
- |
- |
3.69E-01 (FIAVGYVDDTQFVR;DGEDQTQDTELVETR;DGEDQTQDTELVETRPAGDGTFQK;WAAVVVPSGKEKR;YFFTSVSR;APWIEQEGPEYWDGETR;GYHQYAYDGKDYIALK;HKWEAAHVAEQLR;WEAAHVAEQLR) |
- |
1 |
IPI00644631.3
|
4225 |
IPI00644671.1 |
coiled-coil and C2 domain containing 1B |
Nucl(G2) |
- |
- |
- |
1.54E-02 (IHNYREAAASAK;GQPVDLSAMPPAPEDLK) |
- |
- |
4 |
IPI00641630.1, IPI00644671.1, IPI00646418.1, IPI00792905.1
|
4226 |
IPI00644674.1 |
Nucleotide-binding protein 2 |
Cyto(G1) |
- |
2.21E-01 (VGILDVDLCGPSIPR;HIILVLSGK;TLEEGHDFIQEFPGSPAFAALTSIAQK;EQSISLMSVGFLLEK;KVGILDVDLCGPSIPR) |
- |
- |
- |
- |
1 |
IPI00644674.1
|
4227 |
IPI00644680.2 |
similar to Zinc finger protein 469 |
Nucl(G2) |
- |
3.15E-03 (PHPGAPAEPSPAALPAQQPLEPLAQK;SLGDLPGGLEGSSAVAHLLNSITEPAPK) |
4.17E-03 (SKDTRGAPR;EPEDPGTPETGR) |
- |
- |
- |
1 |
IPI00644680.2
|
4228 |
IPI00644697.2 |
HEBP2 protein (Fragment) |
Mito(SP); Cyto(SP,GO) |
- |
6.59E-01 (APEDAGPQPGSYEIR;NQEQLLTLASILR;VYYTAGYNSPVK;WVSTSVESMDWDSAIQTGFTK;NNEVWLIQK) |
- |
- |
1.30E-01 (APEDAGPQPGSYEIR;NQEQLLTLASILR;VYYTAGYNSPVK) |
- |
1 |
IPI00644697.2
|
4229 |
IPI00644699.2 |
Guanine nucleotide exchange factor DBS |
Cyto(G2,GO) |
- |
7.86E-03 (CQSQDGAEAALQEIEK;EYESILNQDLMEHVR) |
- |
- |
- |
- |
5 |
IPI00004536.4, IPI00297139.1, IPI00477099.1, IPI00644699.2, IPI00793824.1
|
4230 |
IPI00644708.1 |
TIA-1 related protein isoform 2 |
Nucl(G1) |
- |
- |
- |
- |
- |
7.94E-01 (GYGFVSFYNK;DTSNHFHVFVGDLSPEITTEDIK;DVTEVLILQLFSQIGPCK;FEDVVNQSSPK;FSTHESAAHAIVSVNGTTIEGHVVK;TLYVGNLSR) |
3 |
IPI00005615.1, IPI00642600.2, IPI00644708.1
|